The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
The purpose of this study is to understand whether people with Parkinson's Disease and depression have improvement in their symptoms after psilocybin therapy.
- Status
- recruiting
- Phase
- Phase 2
- Institution
- Yale University
- Principal investigator
- Sophie Holmes, PhD
- Start date
- 2026-07-01
- End date
- 2030-07-01
- Registry ID
- NCT07610369
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.